nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—CYP2J2—Cholecalciferol—osteoporosis	0.569	0.587	CbGbCtD
Astemizole—CYP3A7—Estradiol—osteoporosis	0.0445	0.0459	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0445	0.0459	CbGbCtD
Astemizole—ABCB1—Ethinyl Estradiol—osteoporosis	0.0337	0.0347	CbGbCtD
Astemizole—CYP3A5—Estradiol—osteoporosis	0.0334	0.0344	CbGbCtD
Astemizole—CYP3A4—Estropipate—osteoporosis	0.0313	0.0323	CbGbCtD
Astemizole—CYP3A4—Calcitriol—osteoporosis	0.0313	0.0323	CbGbCtD
Astemizole—CYP2D6—Cholecalciferol—osteoporosis	0.0254	0.0262	CbGbCtD
Astemizole—CYP3A4—Ergocalciferol—osteoporosis	0.025	0.0258	CbGbCtD
Astemizole—ABCB1—Conjugated Estrogens—osteoporosis	0.0247	0.0255	CbGbCtD
Astemizole—ABCB1—Estradiol—osteoporosis	0.0217	0.0224	CbGbCtD
Astemizole—CYP3A4—Raloxifene—osteoporosis	0.0209	0.0216	CbGbCtD
Astemizole—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0202	0.0208	CbGbCtD
Astemizole—CYP3A4—Cholecalciferol—osteoporosis	0.0161	0.0166	CbGbCtD
Astemizole—CYP3A4—Conjugated Estrogens—osteoporosis	0.0148	0.0153	CbGbCtD
Astemizole—CYP3A4—Estradiol—osteoporosis	0.013	0.0134	CbGbCtD
Astemizole—KCNH2—SIDS Susceptibility Pathways—IL6R—osteoporosis	9.97e-05	0.00329	CbGpPWpGaD
Astemizole—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.92e-05	0.00327	CbGpPWpGaD
Astemizole—CYP3A7—Biological oxidations—CYP19A1—osteoporosis	9.83e-05	0.00324	CbGpPWpGaD
Astemizole—CYP3A7—Metapathway biotransformation—CYP19A1—osteoporosis	9.7e-05	0.0032	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	9.62e-05	0.00317	CbGpPWpGaD
Astemizole—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.52e-05	0.00314	CbGpPWpGaD
Astemizole—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	9.49e-05	0.00313	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	9.49e-05	0.00313	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.47e-05	0.00312	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	9.44e-05	0.00311	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—ADCY5—osteoporosis	8.73e-05	0.00288	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—IDH2—osteoporosis	8.54e-05	0.00281	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	8.09e-05	0.00266	CbGpPWpGaD
Astemizole—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	8.07e-05	0.00266	CbGpPWpGaD
Astemizole—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.04e-05	0.00265	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CYP27A1—osteoporosis	8.03e-05	0.00265	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—ACP5—osteoporosis	7.81e-05	0.00257	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.71e-05	0.00254	CbGpPWpGaD
Astemizole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	7.67e-05	0.00253	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	7.63e-05	0.00252	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—IL1B—osteoporosis	7.59e-05	0.0025	CbGpPWpGaD
Astemizole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	7.57e-05	0.0025	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—TPI1—osteoporosis	7.26e-05	0.00239	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	7.11e-05	0.00234	CbGpPWpGaD
Astemizole—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.05e-05	0.00232	CbGpPWpGaD
Astemizole—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	7.01e-05	0.00231	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—P4HB—osteoporosis	6.83e-05	0.00225	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CALCR—osteoporosis	6.8e-05	0.00224	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PTH1R—osteoporosis	6.8e-05	0.00224	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—GAPDH—osteoporosis	6.7e-05	0.00221	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—RAP1A—osteoporosis	6.53e-05	0.00215	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—PTH—osteoporosis	6.32e-05	0.00208	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	6.29e-05	0.00207	CbGpPWpGaD
Astemizole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.22e-05	0.00205	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	6.2e-05	0.00204	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CALCR—osteoporosis	6.17e-05	0.00203	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PTH1R—osteoporosis	6.17e-05	0.00203	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CNR2—osteoporosis	6.16e-05	0.00203	CbGpPWpGaD
Astemizole—CYP3A7—Biological oxidations—POMC—osteoporosis	5.91e-05	0.00195	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—WNT1—osteoporosis	5.79e-05	0.00191	CbGpPWpGaD
Astemizole—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.72e-05	0.00188	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.69e-05	0.00188	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—FDPS—osteoporosis	5.57e-05	0.00184	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PKM—osteoporosis	5.57e-05	0.00184	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—TNF—osteoporosis	5.5e-05	0.00181	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	5.43e-05	0.00179	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—MGLL—osteoporosis	5.4e-05	0.00178	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PGLS—osteoporosis	5.28e-05	0.00174	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GPD2—osteoporosis	5.28e-05	0.00174	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—ENO1—osteoporosis	5.28e-05	0.00174	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—PTHLH—osteoporosis	5.24e-05	0.00173	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PSMA5—osteoporosis	5.2e-05	0.00171	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PSMA2—osteoporosis	5.2e-05	0.00171	CbGpPWpGaD
Astemizole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	5.09e-05	0.00168	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	5.05e-05	0.00167	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	4.98e-05	0.00164	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—MGLL—osteoporosis	4.9e-05	0.00162	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ATIC—osteoporosis	4.83e-05	0.00159	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PNP—osteoporosis	4.83e-05	0.00159	CbGpPWpGaD
Astemizole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.61e-05	0.00152	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CALCA—osteoporosis	4.61e-05	0.00152	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL1B—osteoporosis	4.46e-05	0.00147	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—IL6—osteoporosis	4.44e-05	0.00146	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—POMC—osteoporosis	4.27e-05	0.00141	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.27e-05	0.00141	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CYP19A1—osteoporosis	4.22e-05	0.00139	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	4.17e-05	0.00138	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—OXCT1—osteoporosis	4.11e-05	0.00135	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CA2—osteoporosis	4.11e-05	0.00135	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SOST—osteoporosis	4.03e-05	0.00133	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PKM—osteoporosis	4.03e-05	0.00133	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—FDPS—osteoporosis	4.03e-05	0.00133	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—MGLL—osteoporosis	4e-05	0.00132	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GPD2—osteoporosis	3.82e-05	0.00126	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PGLS—osteoporosis	3.82e-05	0.00126	CbGpPWpGaD
Astemizole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.74e-05	0.00123	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTH1R—osteoporosis	3.65e-05	0.0012	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CALCR—osteoporosis	3.65e-05	0.0012	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PTH—osteoporosis	3.57e-05	0.00118	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ATIC—osteoporosis	3.49e-05	0.00115	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PNP—osteoporosis	3.49e-05	0.00115	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CNR2—osteoporosis	3.48e-05	0.00115	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.46e-05	0.00114	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—ADCY5—osteoporosis	3.45e-05	0.00114	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—GPX1—osteoporosis	3.43e-05	0.00113	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—IDH2—osteoporosis	3.4e-05	0.00112	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.3e-05	0.00109	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.29e-05	0.00109	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.26e-05	0.00107	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PTH—osteoporosis	3.24e-05	0.00107	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—TNF—osteoporosis	3.23e-05	0.00107	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYP27A1—osteoporosis	3.2e-05	0.00106	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—MTHFR—osteoporosis	3.17e-05	0.00104	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.17e-05	0.00104	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CNR2—osteoporosis	3.16e-05	0.00104	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ACP5—osteoporosis	3.11e-05	0.00103	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—FDPS—osteoporosis	3.04e-05	0.001	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PKM—osteoporosis	3.04e-05	0.001	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—POMC—osteoporosis	3.04e-05	0.001	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—WNT1—osteoporosis	2.97e-05	0.000979	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—OXCT1—osteoporosis	2.97e-05	0.000979	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CA2—osteoporosis	2.97e-05	0.000979	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PTHLH—osteoporosis	2.96e-05	0.000975	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MGLL—osteoporosis	2.9e-05	0.000955	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—TPI1—osteoporosis	2.9e-05	0.000954	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—MGLL—osteoporosis	2.89e-05	0.000954	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GPD2—osteoporosis	2.88e-05	0.00095	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PGLS—osteoporosis	2.88e-05	0.00095	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PKM—osteoporosis	2.86e-05	0.000944	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—FDPS—osteoporosis	2.86e-05	0.000944	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.85e-05	0.00094	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—LRP5—osteoporosis	2.83e-05	0.000932	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—P4HB—osteoporosis	2.72e-05	0.000897	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PGLS—osteoporosis	2.72e-05	0.000895	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GPD2—osteoporosis	2.72e-05	0.000895	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—LRP6—osteoporosis	2.7e-05	0.000891	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PTHLH—osteoporosis	2.69e-05	0.000886	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GAPDH—osteoporosis	2.67e-05	0.000881	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ATIC—osteoporosis	2.64e-05	0.000869	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PNP—osteoporosis	2.64e-05	0.000869	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CALCA—osteoporosis	2.6e-05	0.000859	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—RAP1A—osteoporosis	2.6e-05	0.000858	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—POMC—osteoporosis	2.53e-05	0.000835	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PNP—osteoporosis	2.48e-05	0.000819	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ATIC—osteoporosis	2.48e-05	0.000819	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—IDH2—osteoporosis	2.46e-05	0.000811	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—POMC—osteoporosis	2.41e-05	0.000795	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CALCA—osteoporosis	2.37e-05	0.00078	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.31e-05	0.000763	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TLN1—osteoporosis	2.28e-05	0.000753	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ACP5—osteoporosis	2.25e-05	0.000742	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CA2—osteoporosis	2.24e-05	0.000739	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—OXCT1—osteoporosis	2.24e-05	0.000739	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MGLL—osteoporosis	2.18e-05	0.00072	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CA2—osteoporosis	2.11e-05	0.000696	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—OXCT1—osteoporosis	2.11e-05	0.000696	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ENO1—osteoporosis	2.1e-05	0.000693	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—TPI1—osteoporosis	2.09e-05	0.00069	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PSMA2—osteoporosis	2.07e-05	0.000683	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PSMA5—osteoporosis	2.07e-05	0.000683	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MGLL—osteoporosis	2.06e-05	0.000678	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—POMC—osteoporosis	1.99e-05	0.000655	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—P4HB—osteoporosis	1.97e-05	0.000649	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—P4HB—osteoporosis	1.97e-05	0.000648	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GAPDH—osteoporosis	1.93e-05	0.000637	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTH—osteoporosis	1.92e-05	0.000631	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—RAP1A—osteoporosis	1.88e-05	0.00062	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—RAP1A—osteoporosis	1.88e-05	0.00062	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—FDPS—osteoporosis	1.87e-05	0.000617	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PKM—osteoporosis	1.87e-05	0.000617	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CNR2—osteoporosis	1.87e-05	0.000615	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.86e-05	0.000613	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—IDH2—osteoporosis	1.86e-05	0.000612	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—ADCY5—osteoporosis	1.85e-05	0.000611	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NFATC1—osteoporosis	1.84e-05	0.000605	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DKK1—osteoporosis	1.82e-05	0.0006	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PGLS—osteoporosis	1.78e-05	0.000585	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GPD2—osteoporosis	1.78e-05	0.000585	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—WNT1—osteoporosis	1.76e-05	0.000578	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—IDH2—osteoporosis	1.75e-05	0.000577	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP27A1—osteoporosis	1.75e-05	0.000575	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.71e-05	0.000565	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.71e-05	0.000563	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FGA—osteoporosis	1.71e-05	0.000563	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ACP5—osteoporosis	1.7e-05	0.00056	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—ADCY5—osteoporosis	1.68e-05	0.000555	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.68e-05	0.000554	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.65e-05	0.000542	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ATIC—osteoporosis	1.62e-05	0.000535	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PNP—osteoporosis	1.62e-05	0.000535	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ACP5—osteoporosis	1.6e-05	0.000528	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.6e-05	0.000527	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.6e-05	0.000526	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTHLH—osteoporosis	1.59e-05	0.000523	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—BMP2—osteoporosis	1.59e-05	0.000523	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—TPI1—osteoporosis	1.58e-05	0.00052	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FGB—osteoporosis	1.55e-05	0.000512	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ENO1—osteoporosis	1.52e-05	0.000501	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PSMA5—osteoporosis	1.5e-05	0.000494	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PSMA2—osteoporosis	1.5e-05	0.000494	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PSMA5—osteoporosis	1.5e-05	0.000494	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PSMA2—osteoporosis	1.5e-05	0.000494	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—TPI1—osteoporosis	1.49e-05	0.00049	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—P4HB—osteoporosis	1.48e-05	0.000489	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GAPDH—osteoporosis	1.46e-05	0.00048	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—RAP1A—osteoporosis	1.42e-05	0.000468	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—P4HB—osteoporosis	1.4e-05	0.000461	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CALCA—osteoporosis	1.4e-05	0.000461	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CA2—osteoporosis	1.38e-05	0.000455	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—OXCT1—osteoporosis	1.38e-05	0.000455	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ADCY5—osteoporosis	1.37e-05	0.000453	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GAPDH—osteoporosis	1.37e-05	0.000453	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GPX1—osteoporosis	1.37e-05	0.000451	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—POMC—osteoporosis	1.36e-05	0.000449	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MGLL—osteoporosis	1.35e-05	0.000444	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—RAP1A—osteoporosis	1.34e-05	0.000441	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—KL—osteoporosis	1.27e-05	0.000418	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—MTHFR—osteoporosis	1.26e-05	0.000416	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—POMC—osteoporosis	1.24e-05	0.000408	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.22e-05	0.000401	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.21e-05	0.000398	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ENO1—osteoporosis	1.15e-05	0.000378	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—IDH2—osteoporosis	1.14e-05	0.000377	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PSMA2—osteoporosis	1.13e-05	0.000373	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PSMA5—osteoporosis	1.13e-05	0.000373	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ENO1—osteoporosis	1.08e-05	0.000356	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.08e-05	0.000355	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PSMA2—osteoporosis	1.07e-05	0.000351	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PSMA5—osteoporosis	1.07e-05	0.000351	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ACP5—osteoporosis	1.05e-05	0.000345	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—POMC—osteoporosis	1.01e-05	0.000333	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ADCY5—osteoporosis	9.94e-06	0.000328	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ADCY5—osteoporosis	9.93e-06	0.000327	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GPX1—osteoporosis	9.9e-06	0.000326	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—TPI1—osteoporosis	9.73e-06	0.000321	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SPP1—osteoporosis	9.62e-06	0.000317	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP19A1—osteoporosis	9.17e-06	0.000302	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—P4HB—osteoporosis	9.15e-06	0.000301	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—MTHFR—osteoporosis	9.13e-06	0.000301	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GAPDH—osteoporosis	8.98e-06	0.000296	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—RAP1A—osteoporosis	8.74e-06	0.000288	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IRS2—osteoporosis	8.7e-06	0.000287	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.64e-06	0.000285	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—LEP—osteoporosis	8.51e-06	0.00028	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ESR1—osteoporosis	8.13e-06	0.000268	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IRS1—osteoporosis	7.59e-06	0.00025	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ADCY5—osteoporosis	7.49e-06	0.000247	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GPX1—osteoporosis	7.47e-06	0.000246	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—POMC—osteoporosis	7.31e-06	0.000241	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—POMC—osteoporosis	7.31e-06	0.000241	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL6R—osteoporosis	7.13e-06	0.000235	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ENO1—osteoporosis	7.07e-06	0.000233	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ADCY5—osteoporosis	7.06e-06	0.000233	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GPX1—osteoporosis	7.04e-06	0.000232	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IGF1—osteoporosis	7.03e-06	0.000232	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PSMA2—osteoporosis	6.97e-06	0.00023	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PSMA5—osteoporosis	6.97e-06	0.00023	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MTHFR—osteoporosis	6.89e-06	0.000227	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MTHFR—osteoporosis	6.5e-06	0.000214	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.65e-06	0.000186	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—POMC—osteoporosis	5.51e-06	0.000182	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL6—osteoporosis	5.38e-06	0.000177	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—POMC—osteoporosis	5.19e-06	0.000171	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ADCY5—osteoporosis	4.62e-06	0.000152	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GPX1—osteoporosis	4.6e-06	0.000152	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MTHFR—osteoporosis	4.25e-06	0.00014	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MYC—osteoporosis	4.23e-06	0.000139	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TGFB1—osteoporosis	4.22e-06	0.000139	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—POMC—osteoporosis	3.4e-06	0.000112	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL6—osteoporosis	3.18e-06	0.000105	CbGpPWpGaD
